An ancient founder mutation in PROKR2 impairs human reproduction


Autoria(s): Stefanija, Magdalena Avbelj; Jeanpierre, Marc; Sykiotis, Gerasimos P.; Young, Jacques; Quinton, Richard; Abreu, Ana Paula; Plummer, Lacey; Au, Margaret G.; Balasubramanian, Ravikumar; Dwyer, Andrew A.; Florez, Jose C.; Cheetham, Timothy; Pearce, Simon H.; Purushothaman, Radhika; Schinzel, Albert; Pugeat, Michel; Jacobson-Dickman, Elka E.; Ten, Svetlana; Latronico, Ana Claudia; Gusella, James F.; Dode, Catherine; Crowley, William F., Jr.; Pitteloud, Nelly
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

Congenital gonadotropin-releasing hormone (GnRH) deficiency manifests as absent or incomplete sexual maturation and infertility. Although the disease exhibits marked locus and allelic heterogeneity, with the causal mutations being both rare and private, one causal mutation in the prokineticin receptor, PROKR2 L173R, appears unusually prevalent among GnRH-deficient patients of diverse geographic and ethnic origins. To track the genetic ancestry of PROKR2 L173R, haplotype mapping was performed in 22 unrelated patients with GnRH deficiency carrying L173R and their 30 first-degree relatives. The mutations age was estimated using a haplotype-decay model. Thirteen subjects were informative and in all of them the mutation was present on the same approximate to 123 kb haplotype whose population frequency is 10. Thus, PROKR2 L173R represents a founder mutation whose age is estimated at approximately 9000 years. Inheritance of PROKR2 L173R-associated GnRH deficiency was complex with highly variable penetrance among carriers, influenced by additional mutations in the other PROKR2 allele (recessive inheritance) or another gene (digenicity). The paradoxical identification of an ancient founder mutation that impairs reproduction has intriguing implications for the inheritance mechanisms of PROKR2 L173R-associated GnRH deficiency and for the relevant processes of evolutionary selection, including potential selective advantages of mutation carriers in genes affecting reproduction.

National Institutes of Health

National Institutes of Health [U54 HD028138, R01 HD015788, R01 HD056264, P01 GM061354]

Agence Nationale de la Recherche [ANR-09-GENO-017]

Agence Nationale de la Recherche

Slovene National Research Agency

Slovene National Research Agency [P3-0343]

Identificador

HUMAN MOLECULAR GENETICS, OXFORD, v. 21, n. 19, supl. 1, Part 1, pp. 4314-4324, OCT 1, 2012

0964-6906

http://www.producao.usp.br/handle/BDPI/42072

10.1093/hmg/dds264

http://dx.doi.org/10.1093/hmg/dds264

Idioma(s)

eng

Publicador

OXFORD UNIV PRESS

OXFORD

Relação

HUMAN MOLECULAR GENETICS

Direitos

closedAccess

Copyright OXFORD UNIV PRESS

Palavras-Chave #GONADOTROPIN-RELEASING-HORMONE #IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM #OF-FUNCTION MUTATIONS #KALLMANN-SYNDROME #RECEPTOR GENE #CYSTIC-FIBROSIS #PROKINETICIN 2 #OLFACTORY-BULB #DEFICIENCY #MICE #BIOCHEMISTRY & MOLECULAR BIOLOGY #GENETICS & HEREDITY
Tipo

article

original article

publishedVersion